Nuvation Bio Inc. (NUVB) is a publicly traded company in the Unknown sector. Across all available filings, 22 corporate insiders have executed 89 transactions totaling $97.4M, demonstrating a bearish sentiment with -$47.7M in net insider flow. The most recent transaction on Dec 1, 2025 involved a sale of 150,000 shares valued at $1.2M.
No significant insider buying has been recorded for NUVB in the recent period.
No significant insider selling has been recorded for NUVB in the recent period.
Based on recent SEC filings, insider sentiment for NUVB is bearish with an Insider Alignment Score of 26/100 and a net flow of -$47.7M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at Nuvation Bio Inc. (NUVB) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 22 insiders are actively trading NUVB stock, having executed 89 transactions in the past 90 days. The most active insider is Fund V. Gp Manager, Ltd. Omega (Executive), who has made 7 transactions totaling $32.0M.
Get notified when executives and directors at NUVB file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Dec 1, 2025 | Liu Dongfang | Executive | Sale | 150,000 | $7.82 | $1.2M | Large |
| Dec 1, 2025 | Liu Dongfang | Executive | Option Exercise | 150,000 | $2.93 | $439.5K | |
| Nov 26, 2025 | Liu Dongfang | Executive | Option Exercise | 10,000 | $3.61 | $36.1K | |
| Nov 26, 2025 | Liu Dongfang | Executive | Sale | 10,000 | $8.00 | $80.0K | |
| Nov 25, 2025 | Liu Dongfang | Executive | Option Exercise | 10,000 | $3.61 | $36.1K | |
| Nov 25, 2025 | Liu Dongfang | Executive | Sale | 10,000 | $7.50 | $75.0K | |
| Nov 20, 2025 | Liu Dongfang | Executive | Sale | 20,000 | $7.00 | $140.0K | |
| Nov 20, 2025 | Liu Dongfang | Executive | Option Exercise | 20,000 | $1.87 | $37.4K | |
| Nov 20, 2025 | Hattersley Gary | Executive | Sale | 300,000 | $7.23 | $2.2M | Large |
| Nov 20, 2025 | Hattersley Gary | Executive | Option Exercise | 300,000 | $1.94 | $582.0K | Large |
| Nov 20, 2025 | Hattersley Gary | Executive | Sale | 69,051 | $7.23 | $499.2K | |
| Nov 20, 2025 | Hattersley Gary | Executive | Option Exercise | 69,051 | $1.74 | $120.1K | |
| Nov 19, 2025 | Liu Dongfang | Executive | Sale | 15,000 | $5.10 | $76.5K | |
| Nov 19, 2025 | Liu Dongfang | Executive | Option Exercise | 15,000 | $1.87 | $28.1K | |
| Nov 19, 2025 | C. Hanley David | Executive | Sale | 200,000 | $7.14 | $1.4M | Large |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 20 | $72.6M | 48.0% |
Award(A) | 19 | $50.9M | 33.6% |
Purchase(P) | 26 | $24.9M | 16.4% |
Exercise(M) | 16 | $3.0M | 2.0% |
Conversion(C) | 7 | $0 | 0.0% |
Other(J) | 1 | $0 | 0.0% |
Insider selling pressure at Nuvation Bio Inc. has increased, with 22 insiders executing 89 transactions across all time. Total sales of $72.6M significantly outpace purchases of $24.9M, resulting in a net outflow of $47.7M. This selling activity appears largely discretionary, which may warrant closer attention from investors.